Organon (OGN) Total Current Liabilities (2020 - 2026)

Organon (OGN) posted quarterly Total Current Liabilities of $2.5 billion for Q1 2026, down 4.4% year-over-year from $2.6 billion in Q1 2025, and up 4.6% on a QoQ basis from $2.4 billion in Q4 2025.

Organon (OGN) Total Current Liabilities (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Total Current Liabilities for 7 consecutive years, with $2.5 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 4.4% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 4.4% YoY), while the FY2025 annual figure was $2.4 billion, down 12.07% from the prior year.
  • Total Current Liabilities came in at $2.5 billion for Q1 2026 at Organon, up from $2.4 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $2.9 billion in Q4 2023, with the low at $2.3 billion in Q1 2022.
  • Average Total Current Liabilities over 5 years is $2.6 billion, with a median of $2.5 billion recorded in 2022.
  • Across the five-year window, Total Current Liabilities slipped 25.6% in 2022 and gained 16.16% in 2023, its largest moves.
  • Year by year, Total Current Liabilities stood at $2.5 billion in 2022, then grew by 16.16% to $2.9 billion in 2023, then dropped by 6.85% to $2.7 billion in 2024, then retreated by 12.07% to $2.4 billion in 2025, then gained by 4.6% to $2.5 billion in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $2.5 billion, $2.4 billion, and $2.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 36.63 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 57.72 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 42.10 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -32.57 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 26.95 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 9.48 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 34.35 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 2.50 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.50 Bn
Dec 31, 2025 2.39 Bn
Sep 30, 2025 2.68 Bn
Jun 30, 2025 2.80 Bn
Mar 31, 2025 2.62 Bn
Dec 31, 2024 2.72 Bn
Sep 30, 2024 2.79 Bn
Jun 30, 2024 2.76 Bn
Mar 31, 2024 2.55 Bn
Dec 31, 2023 2.92 Bn
Sep 30, 2023 2.49 Bn
Jun 30, 2023 2.39 Bn
Mar 31, 2023 2.35 Bn
Dec 31, 2022 2.51 Bn
Sep 30, 2022 2.33 Bn
Jun 30, 2022 2.40 Bn
Mar 31, 2022 2.31 Bn
Dec 31, 2021 2.60 Bn
Sep 30, 2021 3.13 Bn
Jun 30, 2021 2.98 Bn